Format

Send to

Choose Destination
BMJ Support Palliat Care. 2019 Apr 4. pii: bmjspcare-2018-001724. doi: 10.1136/bmjspcare-2018-001724. [Epub ahead of print]

Prevalence of depression in patients with cancer in Iran: a systematic review and meta-analysis.

Author information

1
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
2
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
3
Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran ahmad.ghashghaee1996@gmail.com.
4
Student Research Committee, Faculty of Health Management and Information Sciences Branch, Iran University of Medical Sciences, Tehran, Iran.
5
Department of Foreign Languages, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
6
Department of Biology, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.

Abstract

INTRODUCTION:

It is generally accepted that depression, affecting the quality of life, is a serious and common complication in patients with cancer. Given that there is no integrated study on this topic in Iran, the present study sought to investigate the prevalence of depression in patients with cancer by a systematic review and meta-analysis.

METHODS:

To meet the study objectives, all English and Persian papers published from 2000 to January 2018 were systematically collected and the data were extracted for analysis.

RESULTS:

There were 14 studies which were selected on the basis of the inclusion and exclusion criteria. A total number of 2831 patients with cancer had participated in the studies. The prevalence of depression among Iranian patients with cancer was 35% (95% CI 16% to 70%) based on random effects model. Among various types of cancer, the highest prevalence of depression appeared to patients suffering from breast cancer.

CONCLUSION:

The prevalence of depression among patients with cancer in Iran was higher than the developed countries. As depression affects the quality of life of patients with cancer, the results can help policymakers and service providers in planning to reduce the prevalence of depression.

KEYWORDS:

Iran; cancer; depression; multimorbidity; neoplasms

Conflict of interest statement

Competing interests: None declared.

Publication type

Publication type

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center